TearLab

TearLab

TearLab

The TearLab® Osmolarity System is the first objective and quantitative test for diagnosing and managing hyperosmolarity.
Type
B2c
Founded
2003
Raised
$52.8M
Follow us
Alexa global traffic share
Twitter followers
Acquired by
Accelmed
11 May 2020
$25,000,000
Latest funding Show all
$35,000,000
Post-IPO debt - 2015
CRG L.P.
$14,153,846
Post-IPO equity - 2011
PE HUB

Accelmed acquires TearLab